Kidney Cancer Treatment - Complementary & Alternative Medicines

MNT Infect Diseases Health News

Identifying A Molecular-Based Treatment For A Viral Skin Cancer

medicalnewstoday.com — “Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecul” View full resource at medicalnewstoday.com

Most Recently Shared on May 11, 2012 at 7:05 am By:

Identifying A Molecular-Based Treatment For A Viral Skin Cancer http://t.co/reDzqgWe #viruses #bacteria

MNT Ear, Nose Throat Health News

Salivary Gland Damage In Head And Neck Cancer May Be Avoided By Stem Cell Sparing Radiotherapy

medicalnewstoday.com — “Researchers believe they may have found a way to avoid damaging salivary glands during radiotherapy treatment for head and neck cancer - a discovery that could improve the quality of life of 500,0” View full resource at medicalnewstoday.com

Most Recently Shared on May 11, 2012 at 7:05 am By:

Salivary Gland Damage In Head And Neck Cancer May Be Avoided By Stem Cell Sparing Radiotherapy http://t.co/sAUMqroT #entnews

Exhaustion Renders Immune Cells Less Effective In Cancer Treatment

medicalnewstoday.com — “Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to” View full resource at medicalnewstoday.com

Most Recently Shared on May 11, 2012 at 7:05 am By:

MNT Vaccines Health News

Exhaustion Renders Immune Cells Less Effective In Cancer Treatment http://t.co/DYGGZ70P #vaccines #immunesystem

Update on Kinase Inhibitors for CLL: Where Are We Now?

oncologytube.com — “Update on Kinase Inhibitors for CLL: Where Are We Now?: Kinase inhibitors, a newer approach to fighting blood cancers, have been making major strides throughout 2011 for the treatment of CLL. Dr. Susan O'Brien, an investigator of this approach, gives us a...” View full resource at oncologytube.com

Most Recently Shared on May 8, 2012 at 10:29 pm By:

Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive

Update on Kinase inhibitors for CLL: http://t.co/ygaPnoey

Jana Rade Pet Health Advocate

Potential New Treatments for Oral Squamous Cell Carcinoma in Cats

pet-health-care-gazette.com — “New research developments for feline oral squamous cell carcinoma, a common cancer of the mouth in cats.” View full resource at pet-health-care-gazette.com

Most Recently Shared on May 8, 2012 at 4:02 am By:

Potential New Treatment Options for Mouth Cancer (Oral Squamous Cell Carcinoma) in Cats: New resea... http://t.co/wCJP1F6m @LorieAHuston

MNT Cancer News Health News

Curry Ingredient May Have Cancer Treatment Benefits

medicalnewstoday.com — “New evidence, studied by researchers in the Department of Cancer Studies and Molecular Medicine, at the University of Leicester, reveals that curcumin, found in the curry ingredient turmeric,” View full resource at medicalnewstoday.com

Most Recently Shared on May 7, 2012 at 10:05 pm By:

Does Curcumin Have Cancer Treatment Benefits? http://t.co/oiA6uFyG #cancer

Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer

huffingtonpost.com — “By Bill Berkrot NEW YORK, May 7 (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two. Two drugs based on immunotherapy are already available and have met with mixed results. Bristol-Myers Squibb's Yervoy has been hailed as a major breakthrough for treatment of melanoma since its approval last year, w” View full resource at huffingtonpost.com

Most Recently Shared on May 7, 2012 at 8:30 pm By:

Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive

Immunotherapy Drugs: Two Drugs Harness Immune System To Fight #Cancer http://t.co/KXQ728T9 via @HealthyLiving

Thom Canalichio Health News

Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets

newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients w” View full resource at newswise.com

Most Recently Shared on May 7, 2012 at 4:44 pm By:

#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e

Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT... -- SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ --

prnewswire.com — “Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer. New Randomized Study Aims to Provide Comparative Evidence to Support CyberKnife SBRT as the Gold Standard Treatment for Prostate Cancer.” View full resource at prnewswire.com

Most Recently Shared on May 7, 2012 at 4:02 pm By:

RGNJournal Medical Journal and Nursing

@Accuray Study Compares CyberKnife® SBRT to Surgery & IMRT for Treatment of Early-Stage #Prostate #Cancer http://t.co/2Rwp4khM

Natalie's Experience with Skin Cancer - YouTube

youtube.com — “Natalie tells her story about being diagnosed with melanoma, the treatment and the impact it has had on her life.” View full resource at youtube.com

Most Recently Shared on May 7, 2012 at 3:46 pm By:

Dr. Leonard Farber Oncology and Physician Group

True stories on skin cancer http://t.co/Mwqe5Niq

Reuters Health Health News

FDA staff question Pfizer arthritis drug benefits | Reuters

in.reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.The” View full resource at in.reuters.com

Most Recently Shared on May 7, 2012 at 2:36 pm By:

FDA staff question Pfizer arthritis drug benefits http://t.co/WXFuqyft

Researchers separate low and high-PSA prostate cancer cells

news-medical.net — “Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the May 3 edition of Cell Stem Cell.” View full resource at news-medical.net

Most Recently Shared on May 7, 2012 at 12:04 pm By:

john clay mchugh Surgeon, Urologist, Physician, and Doctor

Researchers separate low and high-PSA prostate cancer cells: Prostate cancer cells that defy treatment and displ... http://t.co/Uboq3HWR

MNT Prostate News Health News

Prostate Cancer Stem Cells Identified Among Low-PSA Cells

medicalnewstoday.com — “Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research t” View full resource at medicalnewstoday.com

Most Recently Shared on May 7, 2012 at 8:05 am By:

Prostate Cancer Stem Cells Identified Among Low-PSA Cells http://t.co/PoapPsCd #prostate

MNT Breast Cancer Health News

Improving Hormone-Receptor-Positive Breast Cancer Management Through Progesterone Receptor Expression Measurement

medicalnewstoday.com — “American and Spanish researchers have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests, as t” View full resource at medicalnewstoday.com

Most Recently Shared on May 7, 2012 at 8:05 am By:

Improving Hormone-Receptor-Positive Breast Cancer Management Through Progesterone Receptor Expression Measurement http://t.co/P789yojj